Penn fourth-year Yash Rajpal named 2026-27 Luce Scholar
Yash Rajpal, a University of Pennsylvania fourth-year student in the College of Arts & Sciences and the School of Engineering & Applied Science, is one of 16 recipients selected by the Henry Luce Foundation to be a 2026-27 Luce Scholar.
At Penn, Rajpal serves as a teaching assistant for organic chemistry and calculus, and he worked to develop a super absorptive concrete composition in the Shu Yang Group.
Established in 1974, the Luce Scholars Program is a competitive leadership development fellowship that provides immersive professional experiences in Asia. Its goal is to strengthen relationships across borders by offering opportunities for the Scholars to “deepen their understanding of Asia’s countries, cultures, and people” through deep engagement with communities, “fostering lasting connections and broadening perspectives.”
When the Schuylkill swallowed the city: Lessons from Hurricane Ida’s historic flood
New Penn research shows that Hurricane Ida wasn’t a once-in-a-century anomaly but a preview of how climate change, urbanization, and aging infrastructure are rewriting flood risk.
The Fed explained: What it does and why it matters
Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy
How population changes are impacting primary education worldwide
Research from Penn sociologist Emily Hannum and colleagues reveals regional trends in whether school-age populations are increasing, plateauing, or decreasing—and shows how different countries are responding.
A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.
Fighting oral cancer with bioengineered chewing gum
Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.
